scholarly journals A Pilot Study of Intervention With a Mobile Application Visualizing the Macronutrient Content for Type 2 Diabetes at a Japanese Center

2021 ◽  
Vol 13 (8) ◽  
pp. 425-433
Author(s):  
Asako Tsunemi ◽  
Junko Sato ◽  
Sakae Sugimoto ◽  
Yuko Iwagaki ◽  
Mari Enomoto ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Pilot Study ◽  
Mobile Application ◽  
Macronutrient Content

scholarly journals Type 2 Diabetes: Advancing Real-world Gains in Efficacy Through Technology and Skill Building (TARGETS). A Pilot Evaluation of the Time2Focus Mobile Application for Diabetes Education (Preprint)

2019 ◽  
Author(s):  
Bryan Batch ◽  
Susan Spratt ◽  
Dan Blalock ◽  
Chad Benditz ◽  
Andi Weiss ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Pilot Study ◽  
Self Efficacy ◽  
Mobile Application ◽  
Illness Perceptions ◽  
Diabetes Education ◽  
Severity Of Illness ◽  
Diabetes Distress

BACKGROUND A significant cause of morbidity and mortality, Type 2 diabetes affects 30 million Americans. Self-management support (SMS) is an important component of chronic illness care and is a key pillar of the Chronic Care Model. Face-to-face teaching and patient education materials suffer from being static or incompatible with mobile lifestyles. Digital applications (apps) provide an SMS alternative that is convenient and scalable. OBJECTIVE This pilot study tested the real-world deployment of a self-guided mobile app for diabetes education (titled Time2Focus), which utilizes evidence-based content and gamification to deliver an interactive learning experience. METHODS Primary care providers were approached for permission to invite their patients to participate. Eligible patients were 18 to 89 years of age, had a diagnosis of Type 2 diabetes, hemoglobin A1c (HbA1c) ≥8% and <12% in the past 3 months, an active online patient portal account (tied to the electronic health record), and access to an iOS or Android smartphone. Interested patients were emailed a baseline survey, and once this was completed, sent instructions for downloading the Time2Focus app (MicroMass Communications, Inc; Cary, NC). After completing all 12 levels, participants were sent a follow-up survey. The primary outcome was change in HbA1c. Secondary outcomes included medication adherence, self-care activities, self-reporting of physical activities, diabetes self-efficacy, illness perceptions, diabetes distress scale, and users’ engagement with and rating of the app. RESULTS Of 1355 potentially eligible patients screened, 201 were consented. One hundred (49.7%) did not download the app. Seventeen (8.4%) downloaded the app but completed zero levels. Twenty-six (12.9%) completed 1 through 4 levels, 10 (5.0%) completed 5 through 11 levels, and 48 (23.9%) completed all 12 levels. Those completing one or more levels had a mean pre-/post-HbA1c change of -0.41% (compared to -0.32% among those who completed zero levels). The unadjusted 2-tailed t-test was not statistically significant (p=0.73). Diabetes self-efficacy showed a large and significant increase during app usage (ΔM=1.28, p<.001, d=0.83). Severity of illness perceptions showed a small but significant decrease during app usage (ΔM=-0.51, p=.004, d=0.43). Diabetes distress showed a small but significant decrease during app usage (ΔM=-0.45, p=.006, d=0.41). Net Promoter Score (NPS) was 62.5, indicating those who completed all levels of the app rated it highly and would recommend it to others. CONCLUSIONS Participants who used the Time2Focus mobile application showed an improvement in diabetes self-efficacy and a decrease in severity of illness perceptions. The decrease in HbA1c observed in app users relative to nonusers during this limited pilot study was not statistically significant. However, uptake and application of lessons learned from SMS may be delayed. Further research is needed to address how to increase engagement through SMS and to investigate if follow up over a longer period of time demonstrates significant change in outcomes like HbA1c. CLINICALTRIAL none

1131-P: Endoscopic Duodenal Submucosal Laser Ablation for the Treatment of Type 2 Diabetes Mellitus: Results of First-in-Human Pilot Study

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 1131-P ◽  
Author(s):  
MILOS MRAZ ◽  
IDAN MARCOVITCH ◽  
IVANA LANKOVA ◽  
HELENA KRATOCHVILOVA ◽  
ANNA CINKAJZLOVA ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Laser Ablation ◽  
Pilot Study

973-P: The Feasibility of Continuous Glucose Monitoring in Youth with Type 2 Diabetes Mellitus: A Pilot Study

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 973-P
Author(s):  
ALLISON LAROCHE ◽  
KRISTINA UTZSCHNEIDER ◽  
CATHERINE PIHOKER
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Pilot Study ◽  
Continuous Glucose Monitoring ◽  
Glucose Monitoring

Personalized Behavioral Nutrition Intervention in Older Asian Americans with Type 2 Diabetes during COVID-19 Pandemic: Study Protocol for a Pilot, Hybrid, Randomized Controlled Trial (Preprint)

2020 ◽  
Author(s):  
Jisook Ko ◽  
Yan Du ◽  
Rozmin Jiwani ◽  
Chengdong Li ◽  
Jing Wang
Keyword(s):  
Type 2 Diabetes ◽  
Clinical Trials ◽  
Pilot Study ◽  
Glycemic Control ◽  
Asian Americans ◽  
Control Group ◽  
Management Approach ◽  
Self Monitoring ◽  
Behavioral Nutrition

BACKGROUND The COVID-19 pandemic has challenged the in-person-based self-management approach (i.e., face-to-face or group approach) of type 2 diabetes (T2D). Older adults with T2D, including Asian Americans (AAs), have experienced worsening of diabetes control due to various reasons, including uncertainty of continuous access to essential diabetes medications, devices, education, limited health literacy, as well as constant anxiety and stress. Hybrid clinical trials that incorporate virtual elements into the in-person-based study could provide these vulnerable populations with accessible and timely interventions OBJECTIVE The primary aims of this pilot study are to determine (1) the effect of personalized behavioral nutrition (PBN) intervention on glycemic control, weight control, and metabolites profiles; and (2) the acceptability of PBN. to enhance glycemic control using personalized behavioral nutrition. METHODS Participants will be recruited with a web-based registry, advertisements in ethnic newspapers, and social network services popular among AAs. A total of 60 AAs, aged 65 years or older, who are descendants of Chinese, Korean, or South Asian, and have a diagnosis of T2D will be randomized into two groups: a PBN group (n=30) and a control group (n=30). A 4-week PBN intervention comprises three components: 1) digital self-monitoring; 2) personal nutrition change goals and recommendations; and 3) diabetes nutrition educations. All participants will complete digital self-monitoring on diet, physical activity, and blood glucose. In addition, all participants will access an interactive digital platform to track their self-monitoring data and communicate with the research team. The effectiveness and acceptability of implementing the intervention will be assessed. RESULTS Funding support and institutional review board approval for this study have been secured. Data collection started in August 2020 and is ongoing. CONCLUSIONS To our knowledge, this is the first study to determine the effectiveness and acceptability of PBN utilizing a metabolomics approach and digital-assisted intervention with hybrid RCT among older AAs. The findings of this pilot study will inform the development of a full-scale PBN protocol and hybrid clinical trials that can be adapted for people with T2D in the ongoing pandemic.

An alcohol-free beer enriched with isomaltulose and a resistant dextrin modulates gut microbiome in subjects with type 2 diabetes mellitus and overweight or obesity: a pilot study

2021 ◽  
Author(s):  
Rocío Mateo-Gallego ◽  
Isabel Moreno-Indias ◽  
Ana M. Bea ◽  
Lidia Sánchez-Alcoholado ◽  
Antonio J. Fumanal ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Pilot Study ◽  
Gut Microbiota ◽  
Gut Microbiome ◽  
Low Doses ◽  
Resistant Dextrin ◽  
Overweight Or Obesity

An alcohol-free beer including the substitution of regular carbohydrates for low doses of isomaltulose and maltodextrin within meals significantly impacts gut microbiota in diabetic subjects with overweight or obesity.

Impact of mulberry leaf extract on type 2 diabetes (Mul-DM): A randomized, placebo-controlled pilot study

2017 ◽  
Vol 32 ◽  
pp. 105-108 ◽  
Author(s):  
Daniel M. Riche ◽  
Krista D. Riche ◽  
Honey E. East ◽  
Elizabeth K. Barrett ◽  
Warren L. May
Keyword(s):  
Type 2 Diabetes ◽  
Pilot Study ◽  
Leaf Extract ◽  
Mulberry Leaf ◽  
Mulberry Leaf Extract

Lanarkshire Oximetry Index as a Diagnostic Tool for Peripheral Arterial Disease in Type 2 Diabetes: A Pilot Study

Angiology ◽  
2010 ◽  
Vol 61 (4) ◽  
pp. 388-391 ◽  
Author(s):  
N. Papanas ◽  
D. Kakagia ◽  
K. Papatheodorou ◽  
D. Papazoglou ◽  
M. Alexandridou ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Pilot Study ◽  
Peripheral Arterial Disease ◽  
Diagnostic Tool ◽  
Arterial Disease ◽  
Peripheral Arterial

MTNR1B gene polymorphisms and susceptibility to Type 2 Diabetes: A pilot study in South Indians

Gene ◽  
2015 ◽  
Vol 566 (2) ◽  
pp. 189-193 ◽  
Author(s):  
Mohammed Salman ◽  
Shruti Dasgupta ◽  
A. Cholendra ◽  
P.N. Venugopal ◽  
G.L. Lakshmi ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Pilot Study ◽  
Gene Polymorphisms ◽  
South Indians
Sign in / Sign up

Export Citation Format

Share Document